✦ LIBER ✦

8527 A phase II trial of erlotinib after gemcitabine plus platinum-based chemotherapy in patients (pts) with recurrent and/or metastatic nasopharyngeal carcinoma (NPC)

✍ Scribed by You, B.; Tourneau, C. Le; Chen, E.X.; Chin, S.F.; Wang, L.; Jarvi, A.; Bharadwaj, R.R.; Kamel-Reid, S.; Perez-Ordonez, B.; Siu, L.L.

Book ID: 123488433
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 67 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71618-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine in pati

A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

✍ Daniel T.T. Chua; Jonathan S.T. Sham; Gordon K.H. Au 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

677 Results of a phase II study of cetux

677 Results of a phase II study of cetuximab in combination with carboplatin in patients (pts) with recurrent or metastatic nasopharyngeal carcinoma (R&M NPC) who failed to a platinum-based chemotherapy

✍ A.T. Chan; M.M. Hsu; B.C. Goh; B.B. Ma; T.W. Liu; M. Millward; A. Chang; M. Mues 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 293 KB

A Phase II trial of docetaxel and cispla

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

✍ J.S McCarthy; I.F Tannock; P Degendorfer; T Panzarella; M Furlan; L.L Siu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab

A phase II study of temsirolimus and erl

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

✍ Bauman, Julie E.; Arias-Pulido, Hugo; Lee, Sang-Joon; Fekrazad, M. Houman; Ozawa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 496 KB

Open-label, single-arm phase II study of

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy

✍ Yang Zhang, Liping Zhao, Peiyu Huang, Jingxun Wu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 201 KB